Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
3.470
+0.050 (1.46%)
Aug 25, 2026, 4:00 PM EDT - Market closed
Entera Bio Revenue
In the year 2025, Entera Bio had annual revenue of $42.00K, down -76.80%.
Revenue (ttm)
$42.00K
Revenue Growth
-76.80%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
22
Market Cap
600.80M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 42.00K | -139.00K | -76.80% |
| Dec 31, 2024 | 181.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 134.00K | -437.00K | -76.53% |
| Dec 31, 2021 | 571.00K | 206.00K | 56.44% |
| Dec 31, 2020 | 365.00K | 129.00K | 54.66% |
| Dec 31, 2019 | 236.00K | -264.00K | -52.80% |
| Dec 31, 2018 | 500.00K | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| MiMedx Group | 355.17M |
| Arvinas | 316.70M |
| REGENXBIO | 174.48M |
| ARS Pharmaceuticals | 116.93M |
| Scribe Therapeutics | 36.28M |
| Ovid Therapeutics | 1.58M |
| Artiva Biotherapeutics | 251.00K |
| Altimmune | 31.00K |
ENTX News
- 4 days ago - Entera Bio files to sell 134.8M ordinary shares for holders - TheFly
- 4 days ago - Entera Bio Registration statement: Registration filing - Filings
- 7 days ago - Entera Bio names Riccardo Paolo Camisasca as chief medical officer - TheFly
- 7 days ago - Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation - GlobeNewsWire
- 13 days ago - Entera Bio Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 18 days ago - Entera Announces Second Quarter 2026 Financial Results and Business Updates - GlobeNewsWire
- 18 days ago - Entera Bio Quarterly report: Q2 2026 - Filings
- 18 days ago - Entera Bio Earnings release: Q2 2026 - Filings